However, pharmacological inhibition of PI3K abolished the ability of both puerarin and PJ34 to restore NAD + levels and maintain mitochondrial function, thereby exacerbating hepatic steatosis and metabolic dysregulation induced by HFHSD (117). This evidence concerns the gene PIK3CA and fatty liver disease.